Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Quan Tang

Showing results (481-490 of 515) with videos related to

Pageof 52
Sort By:
BMC Medicine|March 17, 2023
The efficacy and safety of apatinib plus capecitabine in platinum-refractory metastatic and/or recurrent nasopharyngeal carcinoma: a prospective, phase II trialLin-Quan Tang, Xiao-Yun Li, Zhi-Ming Li, et al.
Oncoimmunology|May 8, 2015
Phase I trial of adoptively transferred tumor-infiltrating lymphocyte immunotherapy following concurrent chemoradiotherapy in patients with locoregionally advanced nasopharyngeal carcinomaJiang Li, Qiu-Yan Chen, Jia He, et al.
The New England Journal of Medicine|March 5, 2015
Long-term efficacy of a hepatitis E vaccineJun Zhang, Xue-Feng Zhang, Shou-Jie Huang, et al.
European Journal of Cancer (Oxford, England : 1990)|October 6, 2023
Reduced-dose radiotherapy for Epstein-Barr virus DNA selected staged III nasopharyngeal carcinoma: A single-arm, phase 2 trialShan-Shan Guo, Jin-Hao Yang, Xue-Song Sun, et al.
Cancer Research and Treatment|September 15, 2017
Combination of Tumor Volume and Epstein-Barr Virus DNA Improved Prognostic Stratification of Stage II Nasopharyngeal Carcinoma in the Intensity Modulated Radiotherapy Era: A Large-Scale Cohort StudyQiu-Yan Chen, Shao-Yan Guo, Lin-Quan Tang, et al.
Lancet (London, England)|August 24, 2010
Efficacy and safety of a recombinant hepatitis E vaccine in healthy adults: a large-scale, randomised, double-blind placebo-controlled, phase 3 trialFeng-Cai Zhu, Jun Zhang, Xue-Feng Zhang, et al.
European Journal of Nuclear Medicine and Molecular Imaging|January 9, 2021
Nomogram for the prediction of primary distant metastasis of nasopharyngeal carcinoma to guide individualized application of FDG PET/CTBei-Bei Xiao, Da-Feng Lin, Xue-Song Sun, et al.
Iscience|December 21, 2023
A deep learning-based semiautomated workflow for triaging follow-up MR scans in treated nasopharyngeal carcinomaYing-Ying Huang, Yi-Shu Deng, Yang Liu, et al.
BMC Cancer|December 18, 2015
The impact of the cumulative dose of cisplatin during concurrent chemoradiotherapy on the clinical outcomes of patients with advanced-stage nasopharyngeal carcinoma in an era of intensity-modulated radiotherapyShan-Shan Guo, Lin-Quan Tang, Lu Zhang, et al.
BMC Cancer|February 2, 2018
Pretreatment quality of life as a predictor of survival for patients with nasopharyngeal carcinoma treated with IMRTShan-Shan Guo, Wen Hu, Qiu-Yan Chen, et al.
Pageof 52

Showing results (481-490 of 515) with videos related to

Sort By:
Pageof 52
BMC Medicine|March 17, 2023
The efficacy and safety of apatinib plus capecitabine in platinum-refractory metastatic and/or recurrent nasopharyngeal carcinoma: a prospective, phase II trialLin-Quan Tang, Xiao-Yun Li, Zhi-Ming Li, et al.
Oncoimmunology|May 8, 2015
Phase I trial of adoptively transferred tumor-infiltrating lymphocyte immunotherapy following concurrent chemoradiotherapy in patients with locoregionally advanced nasopharyngeal carcinomaJiang Li, Qiu-Yan Chen, Jia He, et al.
The New England Journal of Medicine|March 5, 2015
Long-term efficacy of a hepatitis E vaccineJun Zhang, Xue-Feng Zhang, Shou-Jie Huang, et al.
European Journal of Cancer (Oxford, England : 1990)|October 6, 2023
Reduced-dose radiotherapy for Epstein-Barr virus DNA selected staged III nasopharyngeal carcinoma: A single-arm, phase 2 trialShan-Shan Guo, Jin-Hao Yang, Xue-Song Sun, et al.
Cancer Research and Treatment|September 15, 2017
Combination of Tumor Volume and Epstein-Barr Virus DNA Improved Prognostic Stratification of Stage II Nasopharyngeal Carcinoma in the Intensity Modulated Radiotherapy Era: A Large-Scale Cohort StudyQiu-Yan Chen, Shao-Yan Guo, Lin-Quan Tang, et al.
Lancet (London, England)|August 24, 2010
Efficacy and safety of a recombinant hepatitis E vaccine in healthy adults: a large-scale, randomised, double-blind placebo-controlled, phase 3 trialFeng-Cai Zhu, Jun Zhang, Xue-Feng Zhang, et al.
European Journal of Nuclear Medicine and Molecular Imaging|January 9, 2021
Nomogram for the prediction of primary distant metastasis of nasopharyngeal carcinoma to guide individualized application of FDG PET/CTBei-Bei Xiao, Da-Feng Lin, Xue-Song Sun, et al.
Iscience|December 21, 2023
A deep learning-based semiautomated workflow for triaging follow-up MR scans in treated nasopharyngeal carcinomaYing-Ying Huang, Yi-Shu Deng, Yang Liu, et al.
BMC Cancer|December 18, 2015
The impact of the cumulative dose of cisplatin during concurrent chemoradiotherapy on the clinical outcomes of patients with advanced-stage nasopharyngeal carcinoma in an era of intensity-modulated radiotherapyShan-Shan Guo, Lin-Quan Tang, Lu Zhang, et al.
BMC Cancer|February 2, 2018
Pretreatment quality of life as a predictor of survival for patients with nasopharyngeal carcinoma treated with IMRTShan-Shan Guo, Wen Hu, Qiu-Yan Chen, et al.
Pageof 52